Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$6.37 - $15.23 $317,340 - $758,728
-49,818 Reduced 44.92%
61,094 $924,000
Q2 2022

Aug 04, 2022

BUY
$4.95 - $9.16 $51,475 - $95,254
10,399 Added 10.35%
110,912 $832,000
Q1 2022

May 05, 2022

SELL
$5.64 - $9.8 $71,802 - $124,763
-12,731 Reduced 11.24%
100,513 $915,000
Q4 2021

Feb 02, 2022

SELL
$7.02 - $13.33 $7,757 - $14,729
-1,105 Reduced 0.97%
113,244 $795,000
Q3 2021

Nov 02, 2021

SELL
$11.32 - $16.63 $72,912 - $107,113
-6,441 Reduced 5.33%
114,349 $1.3 Million
Q2 2021

Aug 02, 2021

BUY
$15.16 - $18.97 $20,314 - $25,419
1,340 Added 1.12%
120,790 $1.93 Million
Q1 2021

May 11, 2021

BUY
$13.12 - $20.9 $835,967 - $1.33 Million
63,717 Added 114.33%
119,450 $2.14 Million
Q4 2020

Feb 08, 2021

BUY
$9.12 - $14.49 $225,564 - $358,381
24,733 Added 79.78%
55,733 $753,000
Q2 2020

Aug 07, 2020

SELL
$12.0 - $16.13 $82,800 - $111,297
-6,900 Reduced 18.21%
31,000 $458,000
Q4 2019

Feb 05, 2020

SELL
$17.72 - $25.1 $95,688 - $135,540
-5,400 Reduced 12.47%
37,900 $916,000
Q2 2019

Aug 09, 2019

SELL
$28.97 - $48.21 $512,334 - $852,593
-17,685 Reduced 29.0%
43,300 $1.28 Million
Q1 2019

May 08, 2019

BUY
$36.32 - $49.25 $947,407 - $1.28 Million
26,085 Added 74.74%
60,985 $2.9 Million
Q4 2018

Feb 08, 2019

SELL
$33.0 - $60.04 $155,100 - $282,188
-4,700 Reduced 11.87%
34,900 $1.26 Million
Q2 2018

Aug 10, 2018

BUY
$47.85 - $70.45 $124,410 - $183,170
2,600 Added 7.03%
39,600 $2.68 Million
Q1 2018

May 10, 2018

BUY
$51.15 - $61.0 $92,070 - $109,800
1,800 Added 5.11%
37,000 $2.01 Million
Q4 2017

Feb 13, 2018

SELL
$50.85 - $65.1 $124,633 - $159,560
-2,451 Reduced 6.51%
35,200 $2.1 Million
Q3 2017

Nov 06, 2017

SELL
$48.6 - $60.1 $611,047 - $755,637
-12,573 Reduced 25.03%
37,651 $1.83 Million
Q2 2017

Aug 11, 2017

BUY
N/A
50,224
50,224 $2.64 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.